Earnings · China A-shares
Allgens Medical Technology Co. Ltd. Class A (688613) earnings
Allgens Medical Technology Co. Ltd. Class A published its interim report on 2026-08-28: net profit -65.46% year on year, -162122.34% excluding one-off items. Wave Radar's earnings-quality score is 82 of 100 (Sound). The stock moved +6.45% in the 3 trading days after the report.
- Report
- interim report
- Published
- 2026-08-28
- Period end
- 2026-06-30
- Net profit YoY
- -65.46%
- Excl. one-offs YoY
- -162122.34%
- Net profit QoQ
- -4.77%
- Result
- Bad / loss
- Quality score
- 82
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -0.19% | — |
| 3 days | +6.45% | — |
| 7 days | +2.17% | — |
| 14 days | +7.34% | — |
| 30 days | +13.03% | +22.36% |
Report history
Over the last 8 reports, net profit grew year on year in 3 of them. The stock rose in the 3 trading days after 4 of 6 reports (average +1.44%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 interim report | 2026-08-29 | ¥2.75M | -65.46% | — | +4.03% | 0.02 | 0.19% | +6.45% | +13.03% | +22.36% |
| 2026 Q1 report | 2026-04-29 | ¥1.41M | +35.47% | +45.51% | +14.65% | 0.01 | 0.10% | +4.90% | -19.85% | -20.80% |
| 2025 annual report | 2026-04-29 | ¥13.84M | +209.30% | +96.62% | +8.59% | 0.10 | 0.97% | +4.90% | -19.85% | -20.80% |
| 2025 Q3 report | 2025-10-30 | ¥13.94M | +185.19% | +137.11% | +5.22% | 0.10 | 0.98% | +0.90% | -14.54% | -9.79% |
| 2025 interim report | 2025-08-30 | ¥7.98M | -13.52% | — | -0.20% | 0.06 | 0.56% | -1.05% | +16.30% | +15.46% |
| 2025 Q1 report | 2025-04-26 | ¥1.04M | -84.99% | — | -10.35% | 0.01 | 0.07% | +3.11% | +38.07% | +34.82% |
| 2024 annual report | 2025-04-26 | -¥12.66M | -123.35% | — | -9.03% | -0.09 | -0.91% | +3.11% | +38.07% | +34.82% |
| 2024 Q3 report | 2024-10-29 | ¥4.89M | -90.95% | — | -19.22% | 0.04 | 0.35% | -5.66% | +2.86% | +2.57% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.